Schroeder, A; Fahrenholz, F; Schmitt, U
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.J Alzheimers Dis. Bd. 16. H. 2. 2009 S. 309-14
Schulte-Herbrüggen, O; Fuchs, E; Ziegler, A et al.
Effects of escitalopram on the regulation of BDNF and NGF protein levels in a rat model of chronic stressJ Neurosci Res. Bd. 87. H. 11. 2009 S. 2551-2560
Jacob, GA; Hellstern, K; Ower, N et al.
Emotional reactions to standardized stimuli in women with borderline personality disorder: stronger negative affect, but no differences in reactivityJ Nerv Ment Dis. Bd. 197. H. 11. 2009 S. 808-15
Zernig, G; Hiemke, C; Havemann-Reinecke, U et al.
Empfehlungen für die gutachterliche Bewertung von Medikamentenspiegeln in der Psychiatrie im gerichtsanhängigen SchadensfallPsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 57-65
Konrad, A; Vucurevic, G; Musso, F et al.
ErbB4 genotype predicts left frontotemporal structural connectivity in human brainNeuropsychopharmacology. Bd. 34. H. 3. 2009 S. 641-650
Riss, PJ; Debus, F; Hummerich, R et al.
Ex vivo and in vivo Evaluation of [F-18]PR04.MZ in Rodents: A Selective Dopamine Transporter Imaging AgentCHEMMEDCHEM. Bd. 4. H. 9. 2009 S. 1480-1487
Bracht, T; Tuscher, O; Schnell, S et al.
Extraction of prefronto-amygdalar pathways by combining probability mapsPsychiatry Res. Bd. 174. H. 3. 2009 S. 217-22
Müller, H; Eusterschulte, B; Havemann-Reinecke, U et al.
Forensische Aspekte des therapeutischen Drug Monitorings (TDM) in der PsychiatriePsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 52-56
Tadic, A; Wagner, S; Hoch, J et al.
Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality DisorderPsychopathology. Bd. 42. 2009 S. 257-263
Treutlein, J; Cichon, S; Ridinger, M et al.
Genome-wide association study of alcohol dependenceArch Gen Psychiatry. Bd. 66. H. 7. 2009 S. 773-784